Hospital acquisitions trimmed operating costs, but the savings came from payroll more than supplies
Hospital mergers and acquisitions continue to be sold as a route to lower costs, tighter coordination, and stronger purchasing leverage. In a longitudinal analysis of U.S. acute care hospitals from 2016 through 2021, the cost picture looked more restrained than the consolidation narrative often suggests. Acquired hospitals showed significant declines in total operating expenses after merger, but the gains were concentrated in salary-related spending rather than in the supply chain categories many executives hope to improve first.
The practical message is immediate. Consolidation did not reliably translate into broad supply expense relief.
Using propensity score matching and panel regression, the investigators compared acquired hospitals with matched peers and tracked several expense categories over time, including total operating expenses, salary expenses, medical-surgical supply costs, pharmaceutical supply costs, and net income. That design matters because hospital M&A studies often struggle to separate the effect of the transaction from preexisting financial trends, local market changes, and case mix shifts. Here, the longitudinal approach was built to isolate the merger signal rather than simply describe post-deal movement.
Payroll efficiency drove most of the postmerger cost decline
The clearest financial change appeared in labor-related spending. Acquired hospitals experienced significant reductions in total operating expenses in the postmerger period, and those savings were largely explained by streamlined payroll costs. In operational terms, this points to staffing consolidation, management integration, administrative overlap reduction, or some combination of those changes. Labor is the largest and least flexible expense category in many hospitals, so even modest changes can move the overall operating ledger more than supply-side savings ever could.
Supply costs behaved differently. A modest reduction appeared in medical-surgical supply costs one year after acquisition, but pharmaceutical supply costs did not change significantly. The separation between these categories is clinically and operationally meaningful. Medical-surgical supplies are often more amenable to standardization, formulary-style rationalization, vendor consolidation, and bulk purchasing agreements. Pharmaceutical purchasing, by contrast, is shaped by tighter formulary controls, therapeutic substitution constraints, drug shortages, contract structures, and regulatory limits that can blunt the effect of consolidation on price or utilization. The result is a narrower window for savings than many acquisition models assume.
Why supply chain synergy is harder to capture than executives expect
Hospital leaders often justify mergers with the expectation that a larger system will negotiate better prices and remove waste from procurement. This study offers a more skeptical counterweight. Supply chain cost savings are easy to forecast on paper, but they are harder to realize once two organizations with different vendors, purchasing rules, inventory systems, and clinical preferences have to operate as one. Integration friction can delay standardization long enough for expected savings to fade or never materialize at all.
The finding also suggests that not all expense categories respond to the same integration strategy. Payroll reductions can occur relatively quickly because they follow structural consolidation of management, back-office functions, and duplicated roles. Supply chain savings depend on operational alignment across clinical departments, materials management, pharmacy, contracting, and frontline purchasing behavior. Without synchronized execution, a merger may change ownership without changing procurement behavior in a way that meaningfully lowers costs.
A merger can shrink overhead and still leave the drug spend untouched.
What hospital boards and supply leaders should infer from the data
For health system executives, the study favors a more selective approach to acquisition planning. Target selection should not rest on financial scale alone. Compatibility in supply chain operations, contracting strategy, and vendor relationships may determine whether promised synergies arrive at all. When organizations with compatible procurement structures merge, the path to savings is likely smoother. When those structures conflict, integration work can become expensive, slow, and only partially effective.
The analysis also argues for earlier supply chain involvement in merger planning. Procurement teams should not be brought in after the corporate transaction is already finalized and the integration timeline is set. Their participation is needed before day one, when leaders are deciding which systems, contracts, formularies, inventory models, and purchasing controls will survive the transition. Post-acquisition planning that ignores those details risks capturing only the easiest efficiencies while missing the harder, but often more valued, supply-side gains.
From a bedside perspective, these cost shifts may never be visible to clinicians in the way a new service line or staffing model is visible. Yet they influence the resources available for care delivery, the stability of supply access, and the financial pressure that systems place on departments. If acquisitions are expected to support patient care through efficiency, the efficiency must come from more than simply reducing headcount.
Net income and the limits of a familiar consolidation story
The study also examined net income, adding another layer to the financial profile of acquired hospitals. The abstract does not present a detailed income effect, but the overall pattern is still instructive: operating expense relief occurred, yet the savings were uneven across categories and modest where supply chain efficiency was expected to shine. That pattern complicates the common assumption that bigger hospital systems automatically extract broad purchasing advantages from scale.
In practice, the deal logic may need to shift from “Can we buy better?” to “Can we operate together?” Those are not the same question. The first focuses on leverage; the second depends on integration discipline, harmonized processes, and willingness to standardize across institutions that may have spent years building separate procurement cultures.
The article leaves one central operational challenge in view: hospital consolidation can reduce expense, but the savings are not guaranteed to come from the supply chain. In this cohort, payroll did most of the work, and pharmaceutical purchasing did not budge in a statistically meaningful way. For health systems that still view M&A as a shortcut to procurement efficiency, that should temper expectations before the next deal closes.